EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

FFA-Induced Hypertension and Endothelial Dysfunction

Not Applicable

Completed

Conditions: Endothelial Dysfunction
Hypertension

Interventions: Drug: Intralipid 20% @ 20cc/hour
Dietary Supplement: 64-gram oral fat load
Drug: Intralipid 20%@ 40cc/hour
Drug: Normal Saline
Dietary Supplement: 32-gram oral fat load

First Posted Date: 2008-01-10

Last Posted Date: 2018-10-16

Lead Sponsor: Emory University

Target Recruit Count: 13

Registration Number: NCT00589888

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States

Age and Endothelial Progenitor Cell Mobilization

Completed

Conditions: Coronary Artery Disease

Interventions: Procedure: Percutaneous Coronary Angioplasty
Procedure: Angiography

First Posted Date: 2008-01-04

Last Posted Date: 2020-03-05

Lead Sponsor: Emory University

Target Recruit Count: 123

Registration Number: NCT00585949

Locations: 🇺🇸
Atlanta VA Medical Center, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Genomic Tools for Studying the Ecology of the Human Vaginal Microflora

Completed

Conditions: Healthy

First Posted Date: 2007-12-19

Last Posted Date: 2016-02-02

Lead Sponsor: Emory University

Target Recruit Count: 396

Registration Number: NCT00576797

Locations: 🇺🇸
Adolescent and Young Adult Center (AYAC),UMB, Baltimore, Maryland, United States
🇺🇸
Center for Vaccine Development, University of Maryland, Baltimore, Maryland, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

Evaluation of Atorvastatin on Atherosclerosis Composition

Not Applicable

Completed

Conditions: Atherosclerosis

Interventions: Drug: Atorvastatin

First Posted Date: 2007-12-19

Last Posted Date: 2013-12-24

Lead Sponsor: Emory University

Target Recruit Count: 27

Registration Number: NCT00576576

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Topical 0.4% Ketorolac and Vitreoretinal Surgery

Phase 2

Completed

Conditions: Surgery

Interventions: Drug: Ketorolac

First Posted Date: 2007-12-19

Last Posted Date: 2014-05-14

Lead Sponsor: Emory University

Target Recruit Count: 76

Registration Number: NCT00576329

Locations: 🇺🇸
Emory Eye Clinic, Atlanta, Georgia, United States

Improving Sleep in Nursing Homes

Phase 4

Completed

Conditions: Sleep Deprivation

Interventions: Drug: Placebo
Drug: Ramelteon

First Posted Date: 2007-12-19

Last Posted Date: 2014-08-13

Lead Sponsor: Emory University

Target Recruit Count: 79

Registration Number: NCT00576927

Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease

Phase 4

Terminated

Conditions: Parkinson's Disease

Interventions: Dietary Supplement: Vitamin D3
Dietary Supplement: Vitamin D3 - high dose
Dietary Supplement: Placebo

First Posted Date: 2007-12-11

Last Posted Date: 2017-01-24

Lead Sponsor: Emory University

Target Recruit Count: 31

Registration Number: NCT00571285

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia

Phase 2

Completed

Conditions: Progressive Keratoconus
Corneal Ectasia

Interventions: Procedure: Corneal collagen
Procedure: Sham comparator

First Posted Date: 2007-12-05

Last Posted Date: 2010-09-02

Lead Sponsor: Emory University

Target Recruit Count: 160

Registration Number: NCT00567671

Locations: 🇺🇸
Woolfson Eye Institute, Atlanta, Georgia, United States

Evaluation of BOTOX® With Rehabilitation Therapy for the Treatment of Wrist and Hand Spasticity in Post-Stroke Patients

Early Phase 1

Completed

Conditions: Stroke

Interventions: Drug: Botox and rehab
Drug: Placebo and rehab

First Posted Date: 2007-11-29

Last Posted Date: 2013-08-13

Lead Sponsor: Emory University

Target Recruit Count: 25

Registration Number: NCT00565201

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States

Sensorimotor Gating in Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Behavioral: Acoustic startle testing

First Posted Date: 2007-11-21

Last Posted Date: 2019-08-07

Lead Sponsor: Emory University

Target Recruit Count: 531

Registration Number: NCT00561561

Locations: 🇺🇸
Atlanta VA Medical Center, Decatur, Georgia, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy